The association, which offers information leaflets on therapeutic cannabis use to the public, says it is aware that a significant number of patients already use the drug for therapeutic purposes.
The Merck study "showed a real question mark in the therapeutic marker, " said Roger Newton, chief science officer ofdrug firm Esperion, and a discoverer of Lipitor.